Veritas Genetics
   HOME

TheInfoList



OR:

Veritas Genetics is a
personal genomics Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphi ...
startup based in Danvers,
Massachusetts Massachusetts (Massachusett language, Massachusett: ''Muhsachuweesut assachusett writing systems, məhswatʃəwiːsət'' English: , ), officially the Commonwealth of Massachusetts, is the most populous U.S. state, state in the New England ...
. According to the company's press release, it was among the first companies to offer whole genome sequencing and interpretation for under $1,000. It was co-founded in 2014 by
George M. Church George McDonald Church (born August 28, 1954) is an American geneticist, molecular engineer, chemist, and a serial entrepreneur who is widely regarded as the "Founding Father of Genomics", and a pioneer in personal genomics and synthetic bio ...
, Mirza Cifric,
Preston Estep Preston "Pete" Wayne Estep III is an American biologist and science and technology advocate. He is a graduate of Cornell University, where he did neuroscience research, and he earned a Ph.D. in Genetics from Harvard University. He did his doctora ...
, and Jonathan Zhao. In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their inherited genetic risk including cancer, cardiovascular and carrier status, reaction to certain medications (pharmacogenomics) and more, all based on
whole-genome sequencing Whole genome sequencing (WGS), also known as full genome sequencing, complete genome sequencing, or entire genome sequencing, is the process of determining the entirety, or nearly the entirety, of the DNA sequence of an organism's genome at a ...
results. The company further reduced to cost of whole genome sequencing to only $199 per order during a promotional period which attracted media attention, as this promotional price was far below traditional prices for consumer-grade genome sequencing at the time. CNBC included the company on its Disruptor 50 list in 2018 and 2019. In December 2019, the company announced that it was considering strategic options. In January 2020, the company reversed course and announced that it had obtained further funding, would resume U.S. operations. In March of 2022, Veritas was acquired by leading global digital health provider LetsGetChecked.https://www.letsgetchecked.com/articles/letsgetchecked-to-acquire-veritas-genetics-and-veritas-intercontinental-to-unlock-the-future-of-personalized-at-home-healthcare/


References


External links

* Genomics companies American companies established in 2014 Companies based in Danvers, Massachusetts Biotechnology companies of the United States Biotechnology companies established in 2014 {{tech-company-stub